World Health Organization. Global Tuberculosis Report 2023. (WHO, 2023).
Nyang’wa, B.-T. et al. A 24-week, all-oral regimen for rifampin-resistant tuberculosis. N. Engl. J. Med. 387, 2331–2343 (2022).
World Health Organization. Global Tuberculosis Report 2023. (WHO, 2023).
Nyang’wa, B.-T. et al. A 24-week, all-oral regimen for rifampin-resistant tuberculosis. N. Engl. J. Med. 387, 2331–2343 (2022).